FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2078456513> ?p ?o ?g. }

• W2078456513 endingPage "S381" @default.
• W2078456513 startingPage "S381" @default.
• W2078456513 abstract "Purpose/Objective: The treatment of head and neck cancer with radiation therapy is challenging given the proximity of target volumes to critical structures. The management of recurrent disease is a therapeutic dilemma since many patients have had prior treatment which often limits the feasibility of reoperation or conventional reirradiation without unacceptable morbidity. With the Cyberknife, it is possible to treat extracranial sites with stereotactic radiosurgery (SRS) without the need for external fixation and with the ability to easily fractionate treatment. The purpose of this study was to report our initial experience using the Cyberknife to treat primary and recurrent head and neck cancers and to evaluate its feasibility, toxicity and local control. Materials/Methods: The CyberKnife is a frameless image-guided SRS system which utilizes a 6-MV linear accelerator mounted on a robotic arm with 6 degrees of freedom. From December 2002 to March 2005, 37 sites were treated in 32 patients using the Cyberknife. Sixteen patients received concurrent chemotherapy. Ten patients were treated as a component of primary treatment. Six patients with nasopharyngeal carcinoma received a boost after conventional radiation. Three patients were treated post-operatively to the submandibular fossa, paranasal sinuses, and nose. One patient was treated pre-operatively for a nasal cavity tumor. Twenty patients were treated for locoregionally recurrent disease. The treated sites included the neck (8), paranasal sinuses (5), skin (5), parapharyngeal space (3), nasopharynx (2), and parotid fossa (1). All of these patients had previous external beam radiation to a median dose of 65 Gy (range 44–120). Seven underwent initial surgical resection (3 subtotally resected, 4 with positive margins), 10 were felt to be unresectable, and 3 had failed multiple prior surgeries. Two patients were treated for metastatic disease to the head and neck. The median follow up was 5 months (range 1-31). Acute and late toxicity were assessed using RTOG grading scales. Local control was assessed with follow-up imaging and clinical examination. Results: The median tumor dose was 25 Gy to the 75% isodose line (range 15–30 Gy) in a median of 5 fractions (range 2–10). The median tumor volume was 52.9 cc (range 4.1–723.2). The median cumulative radiation dose to the treated site was 84 Gy (range 28–158). At the time of analysis, 26 patients were alive, 2 are dead, and 4 have been lost to follow up. The local control rate was 81% overall, 100% in patients treated for primary disease, and 69% in those treated for recurrent disease. Of the 26 patients with measurable disease at the time of treatment, 7 had a complete response, 8 had a partial response, 3 had stable disease, 3 had recurrent/progressive disease, 1 died of complications from infection, and 4 were lost to follow up. Of the 6 patients with no measurable disease at the time of treatment, 4 are NED and 2 have recurred locally. Acute toxicities included 2 patients with Grade 3 GI toxicity, 1 with Grade 3 mucositis, and 3 with Grade 4 skin reactions over areas of tumor necrosis. There was no observed Grade 3 or higher late toxicity. Conclusions: Our early experience demonstrates the efficacy and safety of Cyberknife fractionated SRS for select patients with head and neck cancer. This technique offers an effective treatment option in patients with tumors that are unresectable or incompletely resected, previously irradiated, or located in proximity to radiosensitive critical structures. The local control rate is encouraging with an acceptable toxicity profile." @default.
• W2078456513 created "2016-06-24" @default.
• W2078456513 creator A5008175669 @default.
• W2078456513 creator A5043819422 @default.
• W2078456513 creator A5045139134 @default.
• W2078456513 creator A5052024728 @default.
• W2078456513 creator A5064610626 @default.
• W2078456513 creator A5091901327 @default.
• W2078456513 date "2005-10-01" @default.
• W2078456513 modified "2023-10-15" @default.
• W2078456513 title "CyberKnife Fractionated Stereotactic Radiosurgery for the Treatment of Primary and Recurrent Head and Neck Cancer" @default.
• W2078456513 doi "https://doi.org/10.1016/j.ijrobp.2005.07.650" @default.
• W2078456513 hasPublicationYear "2005" @default.
• W2078456513 type Work @default.
• W2078456513 sameAs 2078456513 @default.
• W2078456513 citedByCount "1" @default.
• W2078456513 crossrefType "journal-article" @default.
• W2078456513 hasAuthorship W2078456513A5008175669 @default.
• W2078456513 hasAuthorship W2078456513A5043819422 @default.
• W2078456513 hasAuthorship W2078456513A5045139134 @default.
• W2078456513 hasAuthorship W2078456513A5052024728 @default.
• W2078456513 hasAuthorship W2078456513A5064610626 @default.
• W2078456513 hasAuthorship W2078456513A5091901327 @default.
• W2078456513 hasBestOaLocation W20784565131 @default.
• W2078456513 hasConcept C126838900 @default.
• W2078456513 hasConcept C141071460 @default.
• W2078456513 hasConcept C2776530083 @default.
• W2078456513 hasConcept C2776651944 @default.
• W2078456513 hasConcept C2777955602 @default.
• W2078456513 hasConcept C2778311950 @default.
• W2078456513 hasConcept C2780387249 @default.
• W2078456513 hasConcept C2780474809 @default.
• W2078456513 hasConcept C509974204 @default.
• W2078456513 hasConcept C71924100 @default.
• W2078456513 hasConceptScore W2078456513C126838900 @default.
• W2078456513 hasConceptScore W2078456513C141071460 @default.
• W2078456513 hasConceptScore W2078456513C2776530083 @default.
• W2078456513 hasConceptScore W2078456513C2776651944 @default.
• W2078456513 hasConceptScore W2078456513C2777955602 @default.
• W2078456513 hasConceptScore W2078456513C2778311950 @default.
• W2078456513 hasConceptScore W2078456513C2780387249 @default.
• W2078456513 hasConceptScore W2078456513C2780474809 @default.
• W2078456513 hasConceptScore W2078456513C509974204 @default.
• W2078456513 hasConceptScore W2078456513C71924100 @default.
• W2078456513 hasLocation W20784565131 @default.
• W2078456513 hasOpenAccess W2078456513 @default.
• W2078456513 hasPrimaryLocation W20784565131 @default.
• W2078456513 hasRelatedWork W1513138878 @default.
• W2078456513 hasRelatedWork W2038755520 @default.
• W2078456513 hasRelatedWork W2070435647 @default.
• W2078456513 hasRelatedWork W2114726223 @default.
• W2078456513 hasRelatedWork W2116193022 @default.
• W2078456513 hasRelatedWork W2187019420 @default.
• W2078456513 hasRelatedWork W2320867056 @default.
• W2078456513 hasRelatedWork W2379674209 @default.
• W2078456513 hasRelatedWork W3024055089 @default.
• W2078456513 hasRelatedWork W956521089 @default.
• W2078456513 hasVolume "63" @default.
• W2078456513 isParatext "false" @default.
• W2078456513 isRetracted "false" @default.
• W2078456513 magId "2078456513" @default.
• W2078456513 workType "article" @default.